You are here

Prescription: Washington

With New Commissioner Aboard, Congress and the FDA Will Emphasize Postmarketing Surveillance and Adverse Reactions

Stephen Barlas
PDF version: 
Stephen Barlas discusses the challenges that face the new FDA Commissioner and Congress in 2007, especially the need to strengthen the FDA’s MedWatch system and its reporting of adverse drug events.